Flt-1-Dependent Survival Characterizes the Epithelial-Mesenchymal Transition of Colonic Organoids
暂无分享,去创建一个
Jeffrey D. Goldsmith | P. Oettgen | M. Shibuya | R. Bachelder | A. Mercurio | R. Bates | Masabumi Shibuya | Courtney Brown | Peter Oettgen | J. Goldsmith | Arthur M. Mercurio | Richard C. Bates | Robin E. Bachelder | Courtney Brown
[1] D. Nettelbeck,et al. Adenovirus-mediated soluble FLT-1 gene therapy for ovarian carcinoma. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[2] R. Warren,et al. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. , 1995, The Journal of clinical investigation.
[3] J. Minna,et al. Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice. , 2000, Cancer research.
[4] T. Noda,et al. Involvement of Flt-1 tyrosine kinase (vascular endothelial growth factor receptor-1) in pathological angiogenesis. , 2001, Cancer research.
[5] A. Ishida,et al. Expression of vascular endothelial growth factor receptors in smooth muscle cells , 2001, Journal of cellular physiology.
[6] A. Mercurio,et al. Tumor necrosis factor-alpha stimulates the epithelial-to-mesenchymal transition of human colonic organoids. , 2003, Molecular biology of the cell.
[7] M. Jäättelä,et al. Escaping cell death: survival proteins in cancer. , 1999, Experimental cell research.
[8] K. Alitalo,et al. Signaling angiogenesis and lymphangiogenesis. , 1998, Current opinion in cell biology.
[9] Thomas N. Sato,et al. Role of the Ets transcription factors in the regulation of the vascular-specific Tie2 gene. , 1999, Circulation research.
[10] J. Thiery. Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.
[11] A. Casalini,et al. Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma , 2001, The Journal of pathology.
[12] R. D'Amato,et al. Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[13] D. Chuang,et al. Different signal transduction pathways are coupled to the nucleotide receptor and the P2Y receptor in C6 glioma cells. , 1994, The Journal of pharmacology and experimental therapeutics.
[14] R. Hay,et al. Intercellular karyotypic similarity in near-diploid cell lines of human tumor origins. , 1983, Cancer genetics and cytogenetics.
[15] S. Aharinejad,et al. Upregulation of vascular endothelial growth factor receptors is associated with advanced neuroblastoma. , 2002, Journal of pediatric surgery.
[16] B. Zetter,et al. Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro. , 1999, Microvascular research.
[17] M. Shibuya,et al. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. , 1994, The Journal of biological chemistry.
[18] N. Ferrara,et al. VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism , 2002, Nature.
[19] S. Natsugoe,et al. Impact of Vascular Endothelial Growth Factor-C and -D Expression in Human Pancreatic Cancer , 2004, Clinical Cancer Research.
[20] K. Shitara,et al. and surface marker for the lineage of monocyte-macrophages in humans Flt-1 , vascular endothelial growth factor receptor 1 , is a novel cell , 2001 .
[21] G. Martiny-Baron,et al. Therapies directed at vascular endothelial growth factor , 2002, Expert opinion on investigational drugs.
[22] B. Wiedenmann,et al. De novo expression of vascular endothelial growth factor in human pancreatic cancer: evidence for an autocrine mitogenic loop. , 2000, Gastroenterology.
[23] H. Beug,et al. TGFβ signaling is necessary for carcinoma cell invasiveness and metastasis , 1998, Current Biology.
[24] P. Savagner,et al. Leaving the neighborhood: molecular mechanisms involved during epithelial‐mesenchymal transition , 2001, BioEssays : news and reviews in molecular, cellular and developmental biology.
[25] E. Hay. An overview of epithelio-mesenchymal transformation. , 1995, Acta anatomica.
[26] H. Moses,et al. Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. , 2001, Molecular biology of the cell.
[27] E. Miyoshi,et al. Transcriptional Regulation of the N-Acetylglucosaminyltransferase V Gene in Human Bile Duct Carcinoma Cells (HuCC-T1) Is Mediated by Ets-1* , 1996, The Journal of Biological Chemistry.
[28] J. Vaillant,et al. Vegf, vegf‐B, vegf‐C and their receptors KDR, FLT‐1 and FLT‐4 during the neoplastic progression of human colonic mucosa , 2000, International journal of cancer.
[29] K. Inoue,et al. Suppression of tumor angiogenesis and growth by gene transfer of a soluble form of vascular endothelial growth factor receptor into a remote organ. , 2000, Cancer research.
[30] J. Winer,et al. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. , 1994, The Journal of biological chemistry.
[31] M. Broggini,et al. Aplidine, a new anticancer agent of marine origin, inhibits vascular endothelial growth factor (VEGF) secretion and blocks VEGF-VEGFR-1 (flt-1) autocrine loop in human leukemia cells MOLT-4 , 2003, Leukemia.
[32] S. Arii,et al. sFlt-1 gene-transfected fibroblasts: a wound-specific gene therapy inhibits local cancer recurrence. , 2001, Cancer research.
[33] M. Shibuya,et al. A cAMP Response Element and an Ets Motif Are Involved in the Transcriptional Regulation of flt-1 Tyrosine Kinase (Vascular Endothelial Growth Factor Receptor 1) Gene* , 1996, The Journal of Biological Chemistry.
[34] H. Hamada,et al. Gene Therapy for Pancreatic Cancer Using an Adenovirus Vector Encoding Soluble flt-1 Vascular Endothelial Growth Factor Receptor , 2002, Pancreas.
[35] Y. Taketani,et al. Soluble FLT-1 expression suppresses carcinomatous ascites in nude mice bearing ovarian cancer. , 2002, Cancer research.
[36] H. Beug,et al. TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. , 1996, Genes & development.
[37] R. Whitehead,et al. A new colon carcinoma cell line (LIM1863) that grows as organoids with spontaneous differentiation into crypt-like structures in vitro. , 1987, Cancer research.
[38] M. Horton,et al. Apoptosis induced by inhibition of intercellular contact , 1994, The Journal of cell biology.
[39] S. Soker,et al. Vascular endothelial growth factor-mediated autocrine stimulation of prostate tumor cells coincides with progression to a malignant phenotype. , 2001, The American journal of pathology.